Your browser doesn't support javascript.
loading
Increased PD-1+ and TIM-3+ TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients.
Jie, Hyun-Bae; Srivastava, Raghvendra M; Argiris, Athanassios; Bauman, Julie E; Kane, Lawrence P; Ferris, Robert L.
Afiliación
  • Jie HB; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Srivastava RM; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Argiris A; Division of Hematology/Oncology, Department of Medicine, UT Health Science Center at San Antonio, Cancer Therapy & Research Center, San Antonio, Texas.
  • Bauman JE; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Kane LP; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Ferris RL; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania. ferrisrl@upmc.edu.
Cancer Immunol Res ; 5(5): 408-416, 2017 05.
Article en En | MEDLINE | ID: mdl-28408386

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Receptor de Muerte Celular Programada 1 / Cetuximab / Receptor 2 Celular del Virus de la Hepatitis A / Antineoplásicos Inmunológicos / Neoplasias de Cabeza y Cuello Límite: Humans Idioma: En Revista: Cancer Immunol Res Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Receptor de Muerte Celular Programada 1 / Cetuximab / Receptor 2 Celular del Virus de la Hepatitis A / Antineoplásicos Inmunológicos / Neoplasias de Cabeza y Cuello Límite: Humans Idioma: En Revista: Cancer Immunol Res Año: 2017 Tipo del documento: Article